The centrality of RXR to nuclear receptor signaling?over a third of NRs heterodimerize with an RXR?suggest that endocrine disruption of RXR signaling could affect the myriad gene expression programs mediated by these receptors, resulting in adverse developmental and metabolic outcomes. We became interested in RXR disruption when RXR agonists surprisingly arose as positive hits in a high throughput quantitative screen we developed for thyroid hormone (TH) receptor (TR) signaling. TRs heterodimerize with RXRs, but in those heterodimers the RXR is thought to be a ?silent? partner, meaning that RXR ligands will not affect the activity of the heterodimer. In rats and humans, prior evidence has shown that Vitamin A or pharmacological rexinoids like bexarotene can effect TH homeostasis in adults. Therefore, the role of RXR agonists in TR transcriptional regulation remains unclear, and the mechanisms through which RXR regulates TH signaling remain a major gap in our understanding. Our hypothesis is that endocrine disruption of RXR can affect TH signaling through TRs during development, creating unforeseen adverse consequences. This may be especially true when the HPT axis is not yet functional or not operating due to TH supplementation. In this proposal we will examine the effects of pharmaceutical and environmental RXR agonists and antagonists on a well-defined in vivo model of TH action: precocious Xenopus metamorphosis. We will define and compare the gene expression programs that RXR disruption affects. In addition, we will use precise genome editing to genetically interrogate the roles of specific RXR subtypes in an intact organism, along with using those editing tools to tag the different RXR and TR subtypes for downstream expression analyses during development. In summary, the Xenopus system is an accessible, rapid and relatively cost efficient means of examining the role of normal and environmental ligand modulated RXR in TR actions in vivo, including both biomedical and environmental toxicological implications in cell-fate specific and developmental stage specific platforms.

Public Health Relevance

Nuclear receptors integrate many hormonal, vitamin and metabolite signaling pathways, and the retinoid-X receptors interact with and influence many of these receptors. Therefore, man-made chemicals in the environment that bind to the retinoid-X receptors could disrupt their function, affecting critical aspects of human health such as development and metabolic homeostasis. Our proposed research will expand our understanding of the role retinoid-X receptor mediated disruption can have on thyroid hormone receptor signaling, as well as create new animal models through genome editing to facilitate expansion of this program into other nuclear receptor signaling networks essential for human health and development. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21ES026271-02
Application #
9334193
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Schug, Thaddeus
Project Start
2016-09-01
Project End
2019-08-31
Budget Start
2017-09-01
Budget End
2019-08-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of California Davis
Department
Physiology
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Mengeling, Brenda J; Wei, Yuzhu; Dobrawa, Lucia N et al. (2017) A multi-tiered, in vivo, quantitative assay suite for environmental disruptors of thyroid hormone signaling. Aquat Toxicol 190:1-10